BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 21753152)

  • 1. Immune modulation by zoledronic acid in human myeloma: an advantageous cross-talk between Vγ9Vδ2 T cells, αβ CD8+ T cells, regulatory T cells, and dendritic cells.
    Castella B; Riganti C; Fiore F; Pantaleoni F; Canepari ME; Peola S; Foglietta M; Palumbo A; Bosia A; Coscia M; Boccadoro M; Massaia M
    J Immunol; 2011 Aug; 187(4):1578-90. PubMed ID: 21753152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced ability of dendritic cells to stimulate innate and adaptive immunity on short-term incubation with zoledronic acid.
    Fiore F; Castella B; Nuschak B; Bertieri R; Mariani S; Bruno B; Pantaleoni F; Foglietta M; Boccadoro M; Massaia M
    Blood; 2007 Aug; 110(3):921-7. PubMed ID: 17403919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular interactions of synovial fluid γδ T cells in juvenile idiopathic arthritis.
    Bendersky A; Marcu-Malina V; Berkun Y; Gerstein M; Nagar M; Goldstein I; Padeh S; Bank I
    J Immunol; 2012 May; 188(9):4349-59. PubMed ID: 22450805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copulsing tumor antigen-pulsed dendritic cells with zoledronate efficiently enhance the expansion of tumor antigen-specific CD8+ T cells via Vgamma9gammadelta T cell activation.
    Takahara M; Miyai M; Tomiyama M; Mutou M; Nicol AJ; Nieda M
    J Leukoc Biol; 2008 Mar; 83(3):742-54. PubMed ID: 18156189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zoledronic acid and interleukin-2 treatment improves immunocompetence in HIV-infected persons by activating Vgamma9Vdelta2 T cells.
    Poccia F; Gioia C; Martini F; Sacchi A; Piacentini P; Tempestilli M; Agrati C; Amendola A; Abdeddaim A; Vlassi C; Malkovsky M; D'Offizi G
    AIDS; 2009 Mar; 23(5):555-65. PubMed ID: 19238075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential requirements of zoledronate-induced cytokine and γδ T cell proliferative responses.
    Nussbaumer O; Gruenbacher G; Gander H; Komuczki J; Rahm A; Thurnher M
    J Immunol; 2013 Aug; 191(3):1346-55. PubMed ID: 23794630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma.
    Mariani S; Muraro M; Pantaleoni F; Fiore F; Nuschak B; Peola S; Foglietta M; Palumbo A; Coscia M; Castella B; Bruno B; Bertieri R; Boano L; Boccadoro M; Massaia M
    Leukemia; 2005 Apr; 19(4):664-70. PubMed ID: 15744346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid alphabeta TCR-mediated responses in gammadelta T cells transduced with cancer-specific TCR genes.
    Hiasa A; Nishikawa H; Hirayama M; Kitano S; Okamoto S; Chono H; Yu SS; Mineno J; Tanaka Y; Minato N; Kato I; Shiku H
    Gene Ther; 2009 May; 16(5):620-8. PubMed ID: 19242528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
    Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary MHC-class II(+) cells are necessary to promote resting Vδ2 cell expansion in response to (E)-4-hydroxy-3-methyl-but-2-enyl-pyrophosphate and isopentenyl pyrophosphate.
    Soriano-Sarabia N; Sandvold H; Jomaa H; Kubin T; Bein G; Hackstein H
    J Immunol; 2012 Dec; 189(11):5212-22. PubMed ID: 23105138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of BCG-induced Th1 immune response through Vgamma9Vdelta2 T cell activation with non-peptidic drugs.
    Martino A; Casetti R; Poccia F
    Vaccine; 2007 Jan; 25(6):1023-9. PubMed ID: 17118497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity.
    Xie Y; Zhang H; Li W; Deng Y; Munegowda MA; Chibbar R; Qureshi M; Xiang J
    J Immunol; 2010 Nov; 185(9):5268-78. PubMed ID: 20881190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zoledronic acid, an aminobisphosphonate, modulates differentiation and maturation of human dendritic cells.
    Chen YJ; Chao KS; Yang YC; Hsu ML; Lin CP; Chen YY
    Immunopharmacol Immunotoxicol; 2009; 31(3):499-508. PubMed ID: 19555208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early triggering of exclusive IFN-gamma responses of human Vgamma9Vdelta2 T cells by TLR-activated myeloid and plasmacytoid dendritic cells.
    Devilder MC; Allain S; Dousset C; Bonneville M; Scotet E
    J Immunol; 2009 Sep; 183(6):3625-33. PubMed ID: 19710464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens.
    Iwasaki M; Tanaka Y; Kobayashi H; Murata-Hirai K; Miyabe H; Sugie T; Toi M; Minato N
    Eur J Immunol; 2011 Feb; 41(2):345-55. PubMed ID: 21268005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells Costimulates pamidronate-activated gammadelta lymphocytes.
    Girlanda S; Fortis C; Belloni D; Ferrero E; Ticozzi P; Sciorati C; Tresoldi M; Vicari A; Spies T; Groh V; Caligaris-Cappio F; Ferrarini M
    Cancer Res; 2005 Aug; 65(16):7502-8. PubMed ID: 16103105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cells.
    Schnurr M; Scholz C; Rothenfusser S; Galambos P; Dauer M; Röbe J; Endres S; Eigler A
    Cancer Res; 2002 Apr; 62(8):2347-52. PubMed ID: 11956095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of zoledronic acid on the function and differentiation of myeloid cells.
    Wolf AM; Rumpold H; Tilg H; Gastl G; Gunsilius E; Wolf D
    Haematologica; 2006 Sep; 91(9):1165-71. PubMed ID: 16956814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.